Inotiv is a contract research organization that provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and sells a range of animals and diets to the same industries. Co.'s segments are: Discovery and Safety Assessment, which includes Discovery Services such as Analytical Method Development and Validation, In Vivo Pharmacology, Exploratory Pharmacokinetics and Toxicology and Archiving services as well as Safety Assessment, such as Non-clinical Toxicology and Pathology Services and Stability Testing; and Research Models and Services, which includes Research Models, Diets and Bedding, and Research Model Services. The NOTV YTD return is shown above.
The YTD Return on the NOTV YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether NOTV YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the NOTV YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.
|